Literature DB >> 23071166

Presymptomatic studies in ALS: rationale, challenges, and approach.

Michael Benatar1, Joanne Wuu.   

Abstract

Mesh：

Year:  2012        PMID： 23071166      PMCID： PMC3468777          DOI： 10.1212/WNL.0b013e31826e9b1d

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  39 in total

Review 1.  The motor cortex and amyotrophic lateral sclerosis.

Authors:  A Eisen; M Weber
Journal:  Muscle Nerve       Date:  2001-04       Impact factor: 3.217

2.  Detection of preclinical motor neurone loss in SOD1 mutation carriers using motor unit number estimation.

Authors:  A Aggarwal; G Nicholson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-08       Impact factor: 10.154

3.  Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.

Authors:  P K Morrish; J S Rakshi; D L Bailey; G V Sawle; D J Brooks
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-03       Impact factor: 10.154

4.  World Federation of Neurology: Research Committee. Research Group on Huntington's chorea. Ethical issues policy statement on Huntington's disease molecular genetics predictive test.

Authors: 
Journal:  J Neurol Sci       Date:  1989-12       Impact factor: 3.181

Review 5.  Amyotrophic lateral sclerosis (ALS): a phylogenetic disease of the corticomotoneuron?

Authors:  A Eisen; S Kim; B Pant
Journal:  Muscle Nerve       Date:  1992-02       Impact factor: 3.217

6.  "You have shown me my end": attitudes toward presymptomatic testing for familial amyotrophic lateral sclerosis.

Authors:  Joanna H Fanos; Deborah F Gelinas; Robert G Miller
Journal:  Am J Med Genet A       Date:  2004-09-01       Impact factor: 2.802

Review 7.  Amyotrophic lateral sclerosis: lower motor neuron disease spreading to upper motor neurons.

Authors:  S M Chou; F H Norris
Journal:  Muscle Nerve       Date:  1993-08       Impact factor: 3.217

8.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

Authors:  D R Rosen; T Siddique; D Patterson; D A Figlewicz; P Sapp; A Hentati; D Donaldson; J Goto; J P O'Regan; H X Deng
Journal:  Nature       Date:  1993-03-04       Impact factor: 49.962

9.  Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder.

Authors:  C H Schenck; S R Bundlie; M W Mahowald
Journal:  Neurology       Date:  1996-02       Impact factor: 9.910

10.  A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

Authors:  Alan E Renton; Elisa Majounie; Adrian Waite; Javier Simón-Sánchez; Sara Rollinson; J Raphael Gibbs; Jennifer C Schymick; Hannu Laaksovirta; John C van Swieten; Liisa Myllykangas; Hannu Kalimo; Anders Paetau; Yevgeniya Abramzon; Anne M Remes; Alice Kaganovich; Sonja W Scholz; Jamie Duckworth; Jinhui Ding; Daniel W Harmer; Dena G Hernandez; Janel O Johnson; Kin Mok; Mina Ryten; Danyah Trabzuni; Rita J Guerreiro; Richard W Orrell; James Neal; Alex Murray; Justin Pearson; Iris E Jansen; David Sondervan; Harro Seelaar; Derek Blake; Kate Young; Nicola Halliwell; Janis Bennion Callister; Greg Toulson; Anna Richardson; Alex Gerhard; Julie Snowden; David Mann; David Neary; Michael A Nalls; Terhi Peuralinna; Lilja Jansson; Veli-Matti Isoviita; Anna-Lotta Kaivorinne; Maarit Hölttä-Vuori; Elina Ikonen; Raimo Sulkava; Michael Benatar; Joanne Wuu; Adriano Chiò; Gabriella Restagno; Giuseppe Borghero; Mario Sabatelli; David Heckerman; Ekaterina Rogaeva; Lorne Zinman; Jeffrey D Rothstein; Michael Sendtner; Carsten Drepper; Evan E Eichler; Can Alkan; Ziedulla Abdullaev; Svetlana D Pack; Amalia Dutra; Evgenia Pak; John Hardy; Andrew Singleton; Nigel M Williams; Peter Heutink; Stuart Pickering-Brown; Huw R Morris; Pentti J Tienari; Bryan J Traynor
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173
View more
  37 in total

1.  ALFF Value in Right Parahippocampal Gyrus Acts as a Potential Marker Monitoring Amyotrophic Lateral Sclerosis Progression: a Neuropsychological, Voxel-Based Morphometry, and Resting-State Functional MRI Study.

Authors:  Wenjia Zhu; Xiaoling Fu; Fang Cui; Fei Yang; Yuting Ren; Xiaoyun Zhang; Xiaolan Zhang; Zhaohui Chen; Li Ling; Xusheng Huang
Journal:  J Mol Neurosci       Date:  2015-06-04       Impact factor: 3.444

2.  Neurofilaments in pre-symptomatic ALS and the impact of genotype.

Authors:  Michael Benatar; Joanne Wuu; Vittoria Lombardi; Andreas Jeromin; Robert Bowser; Peter M Andersen; Andrea Malaspina
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2019-08-21       Impact factor: 4.092

Review 3.  Defining pre-symptomatic amyotrophic lateral sclerosis.

Authors:  Michael Benatar; Martin R Turner; Joanne Wuu
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2019-03-20       Impact factor: 4.092

Review 4.  The imaging signature of C9orf72 hexanucleotide repeat expansions: implications for clinical trials and therapy development.

Authors:  Stacey Li Hi Shing; Mary Clare McKenna; We Fong Siah; Rangariroyashe H Chipika; Orla Hardiman; Peter Bede
Journal:  Brain Imaging Behav       Date:  2021-01-05       Impact factor: 3.978

Review 5.  The presymptomatic phase of amyotrophic lateral sclerosis: are we merely scratching the surface?

Authors:  Rangariroyashe H Chipika; We Fong Siah; Mary Clare McKenna; Stacey Li Hi Shing; Orla Hardiman; Peter Bede
Journal:  J Neurol       Date:  2020-10-31       Impact factor: 6.682

Review 6.  Presymptomatic ALS genetic counseling and testing: Experience and recommendations.

Authors:  Michael Benatar; Christine Stanislaw; Eliana Reyes; Sumaira Hussain; Anne Cooley; Maria Catalina Fernandez; Danielle D Dauphin; Sara-Claude Michon; Peter M Andersen; Joanne Wuu
Journal:  Neurology       Date:  2016-05-18       Impact factor: 9.910

Review 7.  Advances in motor neurone disease.

Authors:  Dirk Bäumer; Kevin Talbot; Martin R Turner
Journal:  J R Soc Med       Date:  2014-01       Impact factor: 5.344

Review 8.  Controversies and priorities in amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Orla Hardiman; Michael Benatar; Benjamin R Brooks; Adriano Chio; Mamede de Carvalho; Paul G Ince; Cindy Lin; Robert G Miller; Hiroshi Mitsumoto; Garth Nicholson; John Ravits; Pamela J Shaw; Michael Swash; Kevin Talbot; Bryan J Traynor; Leonard H Van den Berg; Jan H Veldink; Steve Vucic; Matthew C Kiernan
Journal:  Lancet Neurol       Date:  2013-03       Impact factor: 44.182

Review 9.  The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odyssey.

Authors:  Martin R Turner; Michael Swash
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-02-02       Impact factor: 10.154

Review 10.  What does imaging reveal about the pathology of amyotrophic lateral sclerosis?

Authors:  Martin R Turner; Esther Verstraete
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.